InsidersTradesSigma
Solid Biosciences Inc.: directors' dealings · United States · SEC (Form 4)
SEC:solid-biosciences-inc-d714f0US·SEC (Form 4)Mcap 13M€Technology
Explore the full directors' dealings record of Solid Biosciences Inc., a listed issuer based in United States. Shares trade on US US, under the authority of SEC (Form 4). Operating in the Technology sector, Solid Biosciences Inc. has recorded 4 reports. Market capitalisation: €12.6m. The latest transaction was filed on 5 April 2022 — Levée d'options. Among the most active insiders: SMITH IAN F. All data is accessible without an account.
4
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€27,120
3 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
0.67 €
Analyst consensus
Income statement
Revenue59.3 M€
Gross profit25.3 M€43% margin
Net income−2.6 M€-4.2% margin
Valuation
P/Book1.0x
Beta0.21
Balance sheet & cash
Market cap12.6 M€
Total debt13.1 M€
Free Cash Flow−2.2 M€
Debt / Equity104%
Profitability & ownership
ROE-21.3%
ROA-2.5%
% insiders17.2%
% institutions11.2%
Last declaration on 5 April 2022
Declarations4 total
Executives▼Sale37SEC
€11,33911,269 shares@ €1.00620.090% mcap100.0% of flow
Common Stock
SEC:0001209191-22-018885:0·
Executives▼Sale38SEC
€15,32715,232 shares@ €1.00620.12% mcap100.0% of flow
Common Stock
SEC:0001209191-22-018883:0·
Executives▼Sale30SEC
€454463 shares@ €0.98080.0036% mcap100.0% of flow
Common Stock
SEC:0001209191-22-017114:0·
4 of 4 declarations